The Abnormal Proliferation of Hepatocytes is Associated with MC-LR and C-Terminal Truncated HBX Synergistic Disturbance of the Redox Balance

Microcystin-LR (MC-LR) and hepatitis B virus (HBV) are associated with hepatocellular carcinoma (HCC). However, the concentrations of MC-LR in drinking water and the synergistic effect of MC-LR and HBV on hepatocellular carcinogenesis through their disturbance of redox balance have not been fully el...

Full description

Saved in:
Bibliographic Details
Published inJournal of hepatocellular carcinoma Vol. 9; pp. 1229 - 1246
Main Authors Cai, Dong-Mei, Mei, Fan-Biao, Zhang, Chao-Jun, An, San-Chun, Lv, Rui-Bo, Ren, Guan-Hua, Xiao, Chan-Chan, Long, Long, Huang, Tian-Ren, Deng, Wei
Format Journal Article
LanguageEnglish
Published New Zealand Taylor & Francis Ltd 01.01.2022
Dove
Dove Medical Press
Subjects
Amine oxidase (flavin-containing)
Apoptosis
Bioengineering
Carcinogenesis
Cell cycle
Cell migration
Cell proliferation
Drinking water
Enzymes
Flow cytometry
Gene expression
Genotype & phenotype
Glutathione
Hepatitis B
Hepatitis B surface antigen
hepatitis b virus x gene
Hepatocellular carcinoma
Hepatocytes
Hepatoma
Infections
Liver cancer
Liver diseases
Microcystin-LR
microcystins-lr
Mitochondrial uncoupling protein 2
mRNA
Original Research
Oxidative stress
Pathogenesis
Reactive oxygen species
redox balance
Statistical analysis
Superoxide dismutase
Transaminase
Water quality
Western blotting
United States > US
China
Japan
redox balance
hepatitis B virus X gene
microcystins-LR
hepatocellular carcinoma
Online AccessGet full text

Cover

Abstract Microcystin-LR (MC-LR) and hepatitis B virus (HBV) are associated with hepatocellular carcinoma (HCC). However, the concentrations of MC-LR in drinking water and the synergistic effect of MC-LR and HBV on hepatocellular carcinogenesis through their disturbance of redox balance have not been fully elucidated. We measured the MC-LR concentrations in 168 drinking water samples of areas with a high incidence of HCC. The relationships between MC-LR and both redox status and liver diseases in 177 local residents were analyzed. The hepatoma cell line HepG2 transfected with C-terminal truncated hepatitis B virus X gene (Ct-HBX) were treated with MC-LR. Reactive oxygen species (ROS), superoxide dismutase (SOD), glutathione (GSH) and malondialdehyde (MDA) were measured. Cell proliferation, migration, invasion, and apoptosis were assessed with cell activity assays, scratch and transwell assays, and flow cytometry, respectively. The mRNA and protein expression-related redox status genes were analyzed with qPCR and Western blotting. The average concentration of MC-LR in well water, river water and reservoir water were 57.55 ng/L, 76.74 ng/L and 132.86 ng/L respectively, and the differences were statistically significant (P < 0.05). The MC-LR levels in drinking water were correlated with liver health status, including hepatitis, clonorchiasis, glutamic pyruvic transaminase abnormalities and hepatitis B surface antigen carriage (all P values < 0.05). The serum MDA increased in subjects who drank reservoir water and were infected with HBV (P < 0.05). In the cell experiment, ROS increased when Ct-HBX-transfected HepG2 cells were treated with MC-LR, followed by a decrease in SOD and GSH and an increase in MDA. MC-LR combined with Ct-HBX promoted the proliferation, migration and invasion of HepG2 cells, upregulated the mRNA and protein expression of gene, and downregulated and genes. MC-LR and HBV may synergistically affect redox status and play an important role in hepatocarcinoma genesis.
AbstractList Background: Microcystin-LR (MC-LR) and hepatitis B virus (HBV) are associated with hepatocellular carcinoma (HCC). However, the concentrations of MC-LR in drinking water and the synergistic effect of MC-LR and HBV on hepatocellular carcinogenesis through their disturbance of redox balance have not been fully elucidated. Methods: We measured the MC-LR concentrations in 168 drinking water samples of areas with a high incidence of HCC. The relationships between MC-LR and both redox status and liver diseases in 177 local residents were analyzed. The hepatoma cell line HepG2 transfected with C-terminal truncated hepatitis B virus X gene (Ct-HBX) were treated with MC-LR. Reactive oxygen species (ROS), superoxide dismutase (SOD), glutathione (GSH) and malondialdehyde (MDA) were measured. Cell proliferation, migration, invasion, and apoptosis were assessed with cell activity assays, scratch and transwell assays, and flow cytometry, respectively. The mRNA and protein expression-related redox status genes were analyzed with qPCR and Western blotting. Results: The average concentration of MC-LR in well water, river water and reservoir water were 57.55 ng/L, 76.74 ng/L and 132.86 ng/L respectively, and the differences were statistically significant (P < 0.05). The MC-LR levels in drinking water were correlated with liver health status, including hepatitis, clonorchiasis, glutamic pyruvic transaminase abnormalities and hepatitis B surface antigen carriage (all P values < 0.05). The serum MDA increased in subjects who drank reservoir water and were infected with HBV (P < 0.05). In the cell experiment, ROS increased when Ct-HBX-transfected HepG2 cells were treated with MC-LR, followed by a decrease in SOD and GSH and an increase in MDA. MC-LR combined with Ct-HBX promoted the proliferation, migration and invasion of HepG2 cells, upregulated the mRNA and protein expression of MAOA gene, and downregulated UCP2 and GPX1 genes. Conclusion: MC-LR and HBV may synergistically affect redox status and play an important role in hepatocarcinoma genesis.
Dong-Mei Cai,1,* Fan-Biao Mei,1,* Chao-Jun Zhang,1 San-Chun An,1 Rui-Bo Lv,1 Guan-Hua Ren,1 Chan-Chan Xiao,1 Long Long,1,2 Tian-Ren Huang,1,2 Wei Deng1,2 1Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People’s Republic of China; 2Guangxi Cancer Molecular Medicine Engineering Research Center, Nanning, Guangxi, 530021, People’s Republic of China*These authors contributed equally to this workCorrespondence: Wei Deng; Tianren Huang, Department of Experimental Research, Guangxi Medical University Cancer Hospital, No. 71, Hedi Road, Nanning, Guangxi, 530021, People’s Republic of China, Email dengwei@gxmu.edu.cn; tianrenhuang@sina.comBackground: Microcystin-LR (MC-LR) and hepatitis B virus (HBV) are associated with hepatocellular carcinoma (HCC). However, the concentrations of MC-LR in drinking water and the synergistic effect of MC-LR and HBV on hepatocellular carcinogenesis through their disturbance of redox balance have not been fully elucidated.Methods: We measured the MC-LR concentrations in 168 drinking water samples of areas with a high incidence of HCC. The relationships between MC-LR and both redox status and liver diseases in 177 local residents were analyzed. The hepatoma cell line HepG2 transfected with C-terminal truncated hepatitis B virus X gene (Ct-HBX) were treated with MC-LR. Reactive oxygen species (ROS), superoxide dismutase (SOD), glutathione (GSH) and malondialdehyde (MDA) were measured. Cell proliferation, migration, invasion, and apoptosis were assessed with cell activity assays, scratch and transwell assays, and flow cytometry, respectively. The mRNA and protein expression-related redox status genes were analyzed with qPCR and Western blotting.Results: The average concentration of MC-LR in well water, river water and reservoir water were 57.55 ng/L, 76.74 ng/L and 132.86 ng/L respectively, and the differences were statistically significant (P < 0.05). The MC-LR levels in drinking water were correlated with liver health status, including hepatitis, clonorchiasis, glutamic pyruvic transaminase abnormalities and hepatitis B surface antigen carriage (all P values < 0.05). The serum MDA increased in subjects who drank reservoir water and were infected with HBV (P < 0.05). In the cell experiment, ROS increased when Ct-HBX-transfected HepG2 cells were treated with MC-LR, followed by a decrease in SOD and GSH and an increase in MDA. MC-LR combined with Ct-HBX promoted the proliferation, migration and invasion of HepG2 cells, upregulated the mRNA and protein expression of MAOA gene, and downregulated UCP2 and GPX1 genes.Conclusion: MC-LR and HBV may synergistically affect redox status and play an important role in hepatocarcinoma genesis.Keywords: hepatocellular carcinoma, microcystins-LR, hepatitis B virus X gene, redox balance
Microcystin-LR (MC-LR) and hepatitis B virus (HBV) are associated with hepatocellular carcinoma (HCC). However, the concentrations of MC-LR in drinking water and the synergistic effect of MC-LR and HBV on hepatocellular carcinogenesis through their disturbance of redox balance have not been fully elucidated. We measured the MC-LR concentrations in 168 drinking water samples of areas with a high incidence of HCC. The relationships between MC-LR and both redox status and liver diseases in 177 local residents were analyzed. The hepatoma cell line HepG2 transfected with C-terminal truncated hepatitis B virus X gene (Ct-HBX) were treated with MC-LR. Reactive oxygen species (ROS), superoxide dismutase (SOD), glutathione (GSH) and malondialdehyde (MDA) were measured. Cell proliferation, migration, invasion, and apoptosis were assessed with cell activity assays, scratch and transwell assays, and flow cytometry, respectively. The mRNA and protein expression-related redox status genes were analyzed with qPCR and Western blotting. The average concentration of MC-LR in well water, river water and reservoir water were 57.55 ng/L, 76.74 ng/L and 132.86 ng/L respectively, and the differences were statistically significant (P < 0.05). The MC-LR levels in drinking water were correlated with liver health status, including hepatitis, clonorchiasis, glutamic pyruvic transaminase abnormalities and hepatitis B surface antigen carriage (all P values < 0.05). The serum MDA increased in subjects who drank reservoir water and were infected with HBV (P < 0.05). In the cell experiment, ROS increased when Ct-HBX-transfected HepG2 cells were treated with MC-LR, followed by a decrease in SOD and GSH and an increase in MDA. MC-LR combined with Ct-HBX promoted the proliferation, migration and invasion of HepG2 cells, upregulated the mRNA and protein expression of gene, and downregulated and genes. MC-LR and HBV may synergistically affect redox status and play an important role in hepatocarcinoma genesis.
Microcystin-LR (MC-LR) and hepatitis B virus (HBV) are associated with hepatocellular carcinoma (HCC). However, the concentrations of MC-LR in drinking water and the synergistic effect of MC-LR and HBV on hepatocellular carcinogenesis through their disturbance of redox balance have not been fully elucidated.BackgroundMicrocystin-LR (MC-LR) and hepatitis B virus (HBV) are associated with hepatocellular carcinoma (HCC). However, the concentrations of MC-LR in drinking water and the synergistic effect of MC-LR and HBV on hepatocellular carcinogenesis through their disturbance of redox balance have not been fully elucidated.We measured the MC-LR concentrations in 168 drinking water samples of areas with a high incidence of HCC. The relationships between MC-LR and both redox status and liver diseases in 177 local residents were analyzed. The hepatoma cell line HepG2 transfected with C-terminal truncated hepatitis B virus X gene (Ct-HBX) were treated with MC-LR. Reactive oxygen species (ROS), superoxide dismutase (SOD), glutathione (GSH) and malondialdehyde (MDA) were measured. Cell proliferation, migration, invasion, and apoptosis were assessed with cell activity assays, scratch and transwell assays, and flow cytometry, respectively. The mRNA and protein expression-related redox status genes were analyzed with qPCR and Western blotting.MethodsWe measured the MC-LR concentrations in 168 drinking water samples of areas with a high incidence of HCC. The relationships between MC-LR and both redox status and liver diseases in 177 local residents were analyzed. The hepatoma cell line HepG2 transfected with C-terminal truncated hepatitis B virus X gene (Ct-HBX) were treated with MC-LR. Reactive oxygen species (ROS), superoxide dismutase (SOD), glutathione (GSH) and malondialdehyde (MDA) were measured. Cell proliferation, migration, invasion, and apoptosis were assessed with cell activity assays, scratch and transwell assays, and flow cytometry, respectively. The mRNA and protein expression-related redox status genes were analyzed with qPCR and Western blotting.The average concentration of MC-LR in well water, river water and reservoir water were 57.55 ng/L, 76.74 ng/L and 132.86 ng/L respectively, and the differences were statistically significant (P < 0.05). The MC-LR levels in drinking water were correlated with liver health status, including hepatitis, clonorchiasis, glutamic pyruvic transaminase abnormalities and hepatitis B surface antigen carriage (all P values < 0.05). The serum MDA increased in subjects who drank reservoir water and were infected with HBV (P < 0.05). In the cell experiment, ROS increased when Ct-HBX-transfected HepG2 cells were treated with MC-LR, followed by a decrease in SOD and GSH and an increase in MDA. MC-LR combined with Ct-HBX promoted the proliferation, migration and invasion of HepG2 cells, upregulated the mRNA and protein expression of MAOA gene, and downregulated UCP2 and GPX1 genes.ResultsThe average concentration of MC-LR in well water, river water and reservoir water were 57.55 ng/L, 76.74 ng/L and 132.86 ng/L respectively, and the differences were statistically significant (P < 0.05). The MC-LR levels in drinking water were correlated with liver health status, including hepatitis, clonorchiasis, glutamic pyruvic transaminase abnormalities and hepatitis B surface antigen carriage (all P values < 0.05). The serum MDA increased in subjects who drank reservoir water and were infected with HBV (P < 0.05). In the cell experiment, ROS increased when Ct-HBX-transfected HepG2 cells were treated with MC-LR, followed by a decrease in SOD and GSH and an increase in MDA. MC-LR combined with Ct-HBX promoted the proliferation, migration and invasion of HepG2 cells, upregulated the mRNA and protein expression of MAOA gene, and downregulated UCP2 and GPX1 genes.MC-LR and HBV may synergistically affect redox status and play an important role in hepatocarcinoma genesis.ConclusionMC-LR and HBV may synergistically affect redox status and play an important role in hepatocarcinoma genesis.
Author Lv, Rui-Bo
Mei, Fan-Biao
Long, Long
An, San-Chun
Xiao, Chan-Chan
Ren, Guan-Hua
Huang, Tian-Ren
Cai, Dong-Mei
Deng, Wei
Zhang, Chao-Jun
Author_xml – sequence: 1
  givenname: Dong-Mei
  surname: Cai
  fullname: Cai, Dong-Mei
– sequence: 2
  givenname: Fan-Biao
  surname: Mei
  fullname: Mei, Fan-Biao
– sequence: 3
  givenname: Chao-Jun
  surname: Zhang
  fullname: Zhang, Chao-Jun
– sequence: 4
  givenname: San-Chun
  surname: An
  fullname: An, San-Chun
– sequence: 5
  givenname: Rui-Bo
  surname: Lv
  fullname: Lv, Rui-Bo
– sequence: 6
  givenname: Guan-Hua
  surname: Ren
  fullname: Ren, Guan-Hua
– sequence: 7
  givenname: Chan-Chan
  surname: Xiao
  fullname: Xiao, Chan-Chan
– sequence: 8
  givenname: Long
  surname: Long
  fullname: Long, Long
– sequence: 9
  givenname: Tian-Ren
  surname: Huang
  fullname: Huang, Tian-Ren
– sequence: 10
  givenname: Wei
  orcidid: 0000-0003-0946-5579
  surname: Deng
  fullname: Deng, Wei
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36505941$$D View this record in MEDLINE/PubMed
BookMark eNptkk1vEzEQhleoiJbSE3dkiQsS2tZe27vrC1IaPtIqCNQGiZvl9c4mjjZ2sL1A_gM_GuejqK042R6_88zonXmeHVlnIcteEnxeEFZdXE_G57e0FrxiT7KTouA056IUR_fux9lZCEuMMUkvXNXPsmNacswFIyfZn9kC0Kixzq9Uj75615sOvIrGWeQ6NIG1ik5vIgRkAhqF4LRREVr0y8QF-jzOpzdI2RaN8xn4lbEJMvOD1TvN5PI7ut1Y8HMTotHofToG3yirYQuPqfQNtO43ulT9Nvgie9qpPsDZ4TzNvn38MBtP8umXT1fj0TTXDPOY67It64I2uNGiVBo3lOmW4LKknWiFblnFdcFrShnTUHTQgKh105V1WTGCKdDT7GrPbZ1ayrU3K-U30ikjdwHn51L51HAPEjQlddtVoqow6zhrBBGiI6pL_rVa4MR6t2eth2YFrQYbveofQB_-WLOQc_dTiopSXtYJ8OYA8O7HACHKlQka-uQIuCHIouK0TPOqtrVeP5Iu3eCT5zsVTxaQgiXVq_sd_WvlbuhJQPYC7V0IHjqpTdyNPDVoekmw3O6WTLslD7uVct4-yrnD_k_9F_mzzy0
CitedBy_id crossref_primary_10_1111_cbdd_14461
crossref_primary_10_1016_j_scitotenv_2023_167018
crossref_primary_10_3390_toxins15070411
crossref_primary_10_1016_j_toxicon_2024_108072
Cites_doi 10.1159/000347209
10.1016/j.cca.2004.10.008
10.1016/j.ejca.2012.02.009
10.1016/j.toxicon.2019.11.003
10.1002/jbt.20347
10.1016/j.preteyeres.2021.100941
10.1586/17474124.2015.1028363
10.1128/mcb.21.22.7721-7730.2001
10.1016/j.bbrc.2003.08.113
10.3969/j.issn.1674-5671.2021.02.05
10.1007/s11356-020-10384-0
10.1016/j.ecoenv.2020.110295
10.1002/tox.21918
10.1016/j.canlet.2012.12.004
10.13590/j.cjfh.2020.04.016
10.1016/j.cub.2014.03.034
10.1074/jbc.M301606200
10.1002/jat.2749
10.2471/blt.18.219469
10.1016/S0928-4346(96)82012-3
10.1146/annurev.publhealth.29.020907.090859
10.1016/j.toxlet.2010.10.001
10.1016/j.virusres.2010.10.013
10.16241/j.cnki.1001-5914.2016.11.017
10.3969/j.issn.1674-5671.2016.06.11
10.1016/j.chemosphere.2016.08.002
10.7717/peerj.5955
10.1016/j.jhep.2011.02.015
10.1038/sj.onc.1206889
10.1016/j.biocel.2003.10.012
10.3389/fphar.2020.00089
10.1016/j.chemosphere.2017.10.158
10.1016/j.envpol.2019.05.049
10.1016/j.chemosphere.2017.12.051
10.1016/s0140-6736(18)30010-2
10.1007/s10495-008-0237-2
10.1016/j.toxicon.2009.10.003
10.3892/ol.2017.6296
10.3760/cma.j.issn.0253-3766.2019.10.001
10.1159/000493446
10.1016/j.intimp.2019.03.043
10.1016/j.taap.2019.114626
10.3748/wjg.v20.i20.6236
10.1186/s42826-020-00037-1
10.1080/10590500903585382
10.1289/ehp.00108605
10.1016/j.etap.2011.12.015
10.1093/carcin/bgs406
10.1016/j.ecoenv.2011.10.022
10.1016/j.tox.2006.12.010
10.1016/s1382-6689(00)00049-1
10.1089/ars.2015.6522
ContentType Journal Article
Copyright 2022 Cai et al.
2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 Cai et al. 2022 Cai et al.
Copyright_xml – notice: 2022 Cai et al.
– notice: 2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 Cai et al. 2022 Cai et al.
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K9.
LK8
M0S
M2O
M7P
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.2147/JHC.S389574
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Research Library
Biological Science Database
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Cai et al
EISSN 2253-5969
EndPage 1246
ExternalDocumentID oai_doaj_org_article_ec318df797704f54b9199f1af059dc90
PMC9733568
36505941
10_2147_JHC_S389574
Genre Journal Article
GeographicLocations United States--US
China
Japan
GeographicLocations_xml – name: China
– name: United States--US
– name: Japan
GrantInformation_xml – fundername: ;
GroupedDBID 0YH
5VS
7X7
8FE
8FH
8FI
8FJ
8G5
AAYXX
ABUWG
ADBBV
ADRAZ
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
DWQXO
EMOBN
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
HCIFZ
HMCUK
HYE
IPNFZ
LK8
M2O
M48
M7P
M~E
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RIG
RPM
TDBHL
UKHRP
VDV
NPM
3V.
7XB
8FK
K9.
MBDVC
PKEHL
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c405t-c6d6823b0bc96ac0b34cd10663f9d9cd475c2583344ce2febe98cbf68674103e3
IEDL.DBID M48
ISSN 2253-5969
IngestDate Wed Aug 27 01:30:23 EDT 2025
Thu Aug 21 18:38:54 EDT 2025
Fri Jul 11 15:12:03 EDT 2025
Fri Jul 25 12:00:48 EDT 2025
Thu Jan 02 22:53:31 EST 2025
Tue Jul 01 02:51:55 EDT 2025
Thu Apr 24 23:03:52 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords redox balance
hepatitis B virus X gene
microcystins-LR
hepatocellular carcinoma
Language English
License https://creativecommons.org/licenses/by-nc/3.0
2022 Cai et al.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c405t-c6d6823b0bc96ac0b34cd10663f9d9cd475c2583344ce2febe98cbf68674103e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally to this work
ORCID 0000-0003-0946-5579
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.2147/JHC.S389574
PMID 36505941
PQID 2755106124
PQPubID 3933409
PageCount 18
ParticipantIDs doaj_primary_oai_doaj_org_article_ec318df797704f54b9199f1af059dc90
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9733568
proquest_miscellaneous_2753665070
proquest_journals_2755106124
pubmed_primary_36505941
crossref_citationtrail_10_2147_JHC_S389574
crossref_primary_10_2147_JHC_S389574
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-01-01
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – month: 01
  year: 2022
  text: 2022-01-01
  day: 01
PublicationDecade 2020
PublicationPlace New Zealand
PublicationPlace_xml – name: New Zealand
– name: Macclesfield
PublicationTitle Journal of hepatocellular carcinoma
PublicationTitleAlternate J Hepatocell Carcinoma
PublicationYear 2022
Publisher Taylor & Francis Ltd
Dove
Dove Medical Press
Publisher_xml – name: Taylor & Francis Ltd
– name: Dove
– name: Dove Medical Press
References Zhang (ref54) 2010; 199
Wu (ref56) 2019; 377
Xia (ref4) 1996; 5
Toh (ref30) 2013; 34
Gehringer (ref58) 2004; 36
Zheng (ref13) 2016; 22
Hass (ref59) 2021; 83
Liao (ref40) 2016; 33
Lizzano (ref31) 2011; 155
Li (ref15) 2016; 8
He (ref33) 2017; 10
Jung (ref38) 2013; 331
Chen (ref18) 2019; 252
Lucifora (ref28) 2011; 55
Xiong (ref61) 2010; 24
He (ref19) 2018; 49
Zhang (ref53) 2020; 11
Ma (ref44) 2015; 30
An (ref10) 2019; 41
Zhang (ref17) 2013; 33
Yu (ref35) 2020; 36
Ma (ref45) 2018; 194
Waris (ref36) 2001; 21
Nong (ref42) 2008; 9
Zheng (ref32) 2015; 36
Shirakata (ref37) 2003; 278
Groopman (ref8) 2008; 29
Wei (ref24) 2008; 13
Zhang (ref52) 2012; 77
Ding (ref60) 2019; 71
Hai (ref26) 2014; 20
Wan (ref9) 2020; 27
Takenaka (ref47) 2001; 9
Li (ref11) 2021; 13
Morales (ref43) 2004; 139
Wang (ref2) 2001; 10
Svircev (ref25) 2010; 28
Santin (ref57) 2016; 25
Forner (ref62) 2018; 391
Liu (ref5) 2019; 97
Feng (ref21) 2020; 192
Liu (ref16) 2016; 163
Tang (ref12) 2006; 12
Liu (ref7) 2012; 48
Zhang (ref3) 1996; 5
Shi (ref6) 2020; 32
Krishnan (ref20) 2020; 173
Li (ref49) 2012; 33
He (ref51) 2017; 14
Puerto (ref48) 2010; 55
Xiao (ref39) 2018; 6
Weng (ref23) 2007; 232
Wang (ref50) 2003; 310
Wang (ref29) 2004; 23
Ding (ref46) 2000; 108
(ref55) 2013
Ye (ref1) 1985; 45
Schieber (ref41) 2014; 24
Wallace (ref63) 2015; 9
Gao (ref14) 2016; 32
Ma (ref22) 2018; 192
Fang (ref34) 2017; 10
Ringelhan (ref27) 2013; 31
References_xml – volume: 45
  start-page: 872
  year: 1985
  ident: ref1
  publication-title: Cancer Res
– volume: 36
  start-page: 725
  year: 2015
  ident: ref32
  publication-title: Zhonghua Liu Xing Bing Xue Za Zhi
– volume: 31
  start-page: 138
  year: 2013
  ident: ref27
  publication-title: Dig Dis
  doi: 10.1159/000347209
– volume: 139
  start-page: 153
  year: 2004
  ident: ref43
  publication-title: Comp Biochem Phys Toxicol Pharmacol
  doi: 10.1016/j.cca.2004.10.008
– volume: 48
  start-page: 2125
  year: 2012
  ident: ref7
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2012.02.009
– volume: 10
  start-page: 11857
  year: 2017
  ident: ref34
  publication-title: Int J Clin Exp Pathol
– volume: 173
  start-page: 20
  year: 2020
  ident: ref20
  publication-title: Toxicon
  doi: 10.1016/j.toxicon.2019.11.003
– volume: 24
  start-page: 361
  year: 2010
  ident: ref61
  publication-title: J Biochem Mol Toxicol
  doi: 10.1002/jbt.20347
– volume: 12
  start-page: 1857
  year: 2006
  ident: ref12
  publication-title: Guangxi Med J
– volume: 83
  start-page: 100941
  year: 2021
  ident: ref59
  publication-title: Prog Retin Eye Res
  doi: 10.1016/j.preteyeres.2021.100941
– volume: 9
  start-page: 765
  year: 2015
  ident: ref63
  publication-title: Expert Rev Gastroenterol Hepatol
  doi: 10.1586/17474124.2015.1028363
– volume: 21
  start-page: 7721
  year: 2001
  ident: ref36
  publication-title: Mol Cell Biol
  doi: 10.1128/mcb.21.22.7721-7730.2001
– volume: 310
  start-page: 32
  year: 2003
  ident: ref50
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2003.08.113
– volume: 10
  start-page: 143
  year: 2001
  ident: ref2
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 13
  start-page: 138
  year: 2021
  ident: ref11
  publication-title: Chin J Oncol Prev Treat
  doi: 10.3969/j.issn.1674-5671.2021.02.05
– volume: 27
  start-page: 45095
  year: 2020
  ident: ref9
  publication-title: Environ Sci Pollut Res Int
  doi: 10.1007/s11356-020-10384-0
– volume: 192
  start-page: 110295
  year: 2020
  ident: ref21
  publication-title: Ecotoxicol Environ Saf
  doi: 10.1016/j.ecoenv.2020.110295
– volume: 30
  start-page: 422
  year: 2015
  ident: ref44
  publication-title: Environ Toxicol
  doi: 10.1002/tox.21918
– volume: 331
  start-page: 76
  year: 2013
  ident: ref38
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2012.12.004
– volume: 32
  start-page: 432
  year: 2020
  ident: ref6
  publication-title: Chin J Food Hyg
  doi: 10.13590/j.cjfh.2020.04.016
– volume: 22
  start-page: 138
  year: 2016
  ident: ref13
  publication-title: J Appl Prev Med
– volume: 24
  start-page: R453
  year: 2014
  ident: ref41
  publication-title: Curr Biol
  doi: 10.1016/j.cub.2014.03.034
– volume: 278
  start-page: 22071
  year: 2003
  ident: ref37
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M301606200
– volume: 33
  start-page: 1180
  year: 2013
  ident: ref17
  publication-title: J Appl Toxicol
  doi: 10.1002/jat.2749
– volume: 97
  start-page: 230
  year: 2019
  ident: ref5
  publication-title: Bull World Health Organ
  doi: 10.2471/blt.18.219469
– volume: 5
  start-page: 62
  year: 1996
  ident: ref4
  publication-title: Int Hepatol Commun
  doi: 10.1016/S0928-4346(96)82012-3
– volume: 29
  start-page: 187
  year: 2008
  ident: ref8
  publication-title: Annu Rev Public Health
  doi: 10.1146/annurev.publhealth.29.020907.090859
– volume: 199
  start-page: 377
  year: 2010
  ident: ref54
  publication-title: Toxicol Lett
  doi: 10.1016/j.toxlet.2010.10.001
– volume: 155
  start-page: 231
  year: 2011
  ident: ref31
  publication-title: Virus Res
  doi: 10.1016/j.virusres.2010.10.013
– volume-title: Biomarkers of Exposure to Microcystin-LR and Apoptotic Effects Induced by the Toxin in Mice
  year: 2013
  ident: ref55
– volume: 5
  start-page: 18
  year: 1996
  ident: ref3
  publication-title: China Cancer
– volume: 33
  start-page: 1003
  year: 2016
  ident: ref40
  publication-title: J Environ Health
  doi: 10.16241/j.cnki.1001-5914.2016.11.017
– volume: 8
  start-page: 387
  year: 2016
  ident: ref15
  publication-title: Chin J Oncol Prev Treat
  doi: 10.3969/j.issn.1674-5671.2016.06.11
– volume: 163
  start-page: 14
  year: 2016
  ident: ref16
  publication-title: Chemosphere
  doi: 10.1016/j.chemosphere.2016.08.002
– volume: 6
  start-page: e5955
  year: 2018
  ident: ref39
  publication-title: PeerJ
  doi: 10.7717/peerj.5955
– volume: 55
  start-page: 996
  year: 2011
  ident: ref28
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2011.02.015
– volume: 23
  start-page: 142
  year: 2004
  ident: ref29
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1206889
– volume: 36
  start-page: 931
  year: 2004
  ident: ref58
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2003.10.012
– volume: 11
  start-page: 89
  year: 2020
  ident: ref53
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2020.00089
– volume: 192
  start-page: 305
  year: 2018
  ident: ref22
  publication-title: Chemosphere
  doi: 10.1016/j.chemosphere.2017.10.158
– volume: 252
  start-page: 216
  year: 2019
  ident: ref18
  publication-title: Environ Pollut
  doi: 10.1016/j.envpol.2019.05.049
– volume: 194
  start-page: 773
  year: 2018
  ident: ref45
  publication-title: Chemosphere
  doi: 10.1016/j.chemosphere.2017.12.051
– volume: 391
  start-page: 1301
  year: 2018
  ident: ref62
  publication-title: Lancet
  doi: 10.1016/s0140-6736(18)30010-2
– volume: 13
  start-page: 1031
  year: 2008
  ident: ref24
  publication-title: Apoptosis
  doi: 10.1007/s10495-008-0237-2
– volume: 55
  start-page: 514
  year: 2010
  ident: ref48
  publication-title: Toxicon
  doi: 10.1016/j.toxicon.2009.10.003
– volume: 14
  start-page: 1323
  year: 2017
  ident: ref51
  publication-title: Oncol Lett
  doi: 10.3892/ol.2017.6296
– volume: 41
  start-page: 721
  year: 2019
  ident: ref10
  publication-title: Zhonghua zhong liu za zhi
  doi: 10.3760/cma.j.issn.0253-3766.2019.10.001
– volume: 49
  start-page: 1420
  year: 2018
  ident: ref19
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000493446
– volume: 71
  start-page: 336
  year: 2019
  ident: ref60
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2019.03.043
– volume: 377
  start-page: 114626
  year: 2019
  ident: ref56
  publication-title: Toxicol Appl Pharmacol
  doi: 10.1016/j.taap.2019.114626
– volume: 10
  start-page: 4633
  year: 2017
  ident: ref33
  publication-title: Int J Clin Exp Pathol
– volume: 9
  start-page: 1505
  year: 2008
  ident: ref42
  publication-title: Chin Trop Med
– volume: 20
  start-page: 6236
  year: 2014
  ident: ref26
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v20.i20.6236
– volume: 32
  start-page: 687
  year: 2016
  ident: ref14
  publication-title: Chin J Public Health
– volume: 36
  start-page: 6
  year: 2020
  ident: ref35
  publication-title: Lab Anim Res
  doi: 10.1186/s42826-020-00037-1
– volume: 28
  start-page: 39
  year: 2010
  ident: ref25
  publication-title: J Environ Sci Health C Environ Carcinog Ecotoxicol Rev
  doi: 10.1080/10590500903585382
– volume: 108
  start-page: 605
  year: 2000
  ident: ref46
  publication-title: Environ Health Perspect
  doi: 10.1289/ehp.00108605
– volume: 33
  start-page: 318
  year: 2012
  ident: ref49
  publication-title: Environ Toxicol Pharmacol
  doi: 10.1016/j.etap.2011.12.015
– volume: 34
  start-page: 787
  year: 2013
  ident: ref30
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgs406
– volume: 77
  start-page: 88
  year: 2012
  ident: ref52
  publication-title: Ecotoxicol Environ Saf
  doi: 10.1016/j.ecoenv.2011.10.022
– volume: 232
  start-page: 15
  year: 2007
  ident: ref23
  publication-title: Toxicology
  doi: 10.1016/j.tox.2006.12.010
– volume: 9
  start-page: 135
  year: 2001
  ident: ref47
  publication-title: Environ Toxicol Pharmacol
  doi: 10.1016/s1382-6689(00)00049-1
– volume: 25
  start-page: 10
  year: 2016
  ident: ref57
  publication-title: Antioxid Redox Signal
  doi: 10.1089/ars.2015.6522
SSID ssj0001596078
Score 2.198048
Snippet Microcystin-LR (MC-LR) and hepatitis B virus (HBV) are associated with hepatocellular carcinoma (HCC). However, the concentrations of MC-LR in drinking water...
Background: Microcystin-LR (MC-LR) and hepatitis B virus (HBV) are associated with hepatocellular carcinoma (HCC). However, the concentrations of MC-LR in...
Dong-Mei Cai,1,* Fan-Biao Mei,1,* Chao-Jun Zhang,1 San-Chun An,1 Rui-Bo Lv,1 Guan-Hua Ren,1 Chan-Chan Xiao,1 Long Long,1,2 Tian-Ren Huang,1,2 Wei Deng1,2...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1229
SubjectTerms Amine oxidase (flavin-containing)
Apoptosis
Bioengineering
Carcinogenesis
Cell cycle
Cell migration
Cell proliferation
Drinking water
Enzymes
Flow cytometry
Gene expression
Genotype & phenotype
Glutathione
Hepatitis B
Hepatitis B surface antigen
hepatitis b virus x gene
Hepatocellular carcinoma
Hepatocytes
Hepatoma
Infections
Liver cancer
Liver diseases
Microcystin-LR
microcystins-lr
Mitochondrial uncoupling protein 2
mRNA
Original Research
Oxidative stress
Pathogenesis
Reactive oxygen species
redox balance
Statistical analysis
Superoxide dismutase
Transaminase
Water quality
Western blotting
SummonAdditionalLinks – databaseName: DOAJ Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9tAEF5KDqGX0iZ9uE3LFnIqbCNpH9IeY7dBhLqUxAHfxD5pwEjFsaH5D_3RnVnJxi6BXnIylob1St-3nm8fM0PIaeZlZvLCsqLyFRM6BmYirsFb8IYq8spb3NGdflf1jbicy_lOqS88E9anB-5f3FlwwDofS9ApmYhSWJ1rHXNoUGrvdJqtg8_bmUz18cGgzNPfMPCVM_im--A8LMtzdllPPl-Dp5al2HNHKWv_Q1Lz3xOTOy7o4jl5NmhHet73-QV5EtojcjgddsePyR_AnJ7bFmXogv7Aejwx9AjTLtIaPM-qc_cgLuntHd0AEzzFxVg6nbBvV9S0nk7YrD8is6Cz5RqzxoJNPZ7T63uMFEypnekX-FgvLZIGGwcdSa-C737TMR6WdOElubn4OpvUbKi2wByIthVzyquq4DazTivjACzhfI6KJGqvnReldAXGaAnhQhEBfF05G1WlQJRkPPBX5KDt2vCGUB1dmedB2UppYYzQympginTGRMO9GZFPm5feuCEVOVbEWDQwJUGEGkCoGRAakdOt8a8-A8fDZmNEb2uCabPTBSBTM5Cp-R-ZRuRkg30zjOW7pihBVaIShN_4uL0NoxC3VkwbunWy4QrEbglNvO6psu0Jh-tSi3xEyj0S7XV1_057-zNl-tYl51JVbx_j2d6RpwWGbqTloxNysFquw3sQVCv7IY2dv2HYHiY
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZaxRBEG40gvgi3o5GaSFPwpg5-ph-kuxqGIIrkmxg34Y-NbDMxD0g-Q_50VbN9G5cCT4N9BRNM1911zdV1VWEHGSOZzovTFpUrkqZCj7VAX3wBqyhCGXlDEZ0J99Ffc5OZnwWHW7LmFa5ORP7g9p1Fn3kh4UE2472mH2-_J1i1yiMrsYWGvfJAyxdhildciZvfSwc-Lmshmt52JDn8KQefzoDG80l2zFEfb3-u0jmv7mSfxmf4yfkcWSN9GiA-Sm559tn5OEkxsWfkxtAmx6ZFgnonP7ATjzBD9jSLtAabM6qs9dAK-nFkm4g8Y6iG5ZOxum3U6pbR8fpdEiOmdPpYo31YkGmHs3o2TXeEeyLOtMv8FgvDKoLTg4Mkp56113REaZJWv-CnB9_nY7rNPZZSC3QtVVqhRNVUZrMWCW0BZiYdTlykaCcso5Jbgu8ncWY9UUA2FVlTRCVADqSlb58SfbarvWvCVXByjz3wlRCMa2ZEkaBjnCrddCl0wn5uPnojY1FyLEXxryBnxFEqAGEmohQQg62wpdD7Y27xUaI3lYEC2b3A93iZxP3X-MtHF4uSKC7GQucGZUrFXLQS66cVVlC9jfYN3EXL5tbnUvIh-1r2H8YVNGt79a9TCmA5kqY4tWgKtuVlDDOFcsTIneUaGepu2_ai199jW8ly5KL6s3_l_WWPCrwOkbvEtone6vF2r8DkrQy7_ud8Ae68RPM
  priority: 102
  providerName: ProQuest
Title The Abnormal Proliferation of Hepatocytes is Associated with MC-LR and C-Terminal Truncated HBX Synergistic Disturbance of the Redox Balance
URI https://www.ncbi.nlm.nih.gov/pubmed/36505941
https://www.proquest.com/docview/2755106124
https://www.proquest.com/docview/2753665070
https://pubmed.ncbi.nlm.nih.gov/PMC9733568
https://doaj.org/article/ec318df797704f54b9199f1af059dc90
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9tAEF5yQOlL6V23qdlCngpKdax2tQ-lxG6CCHUIjg3uk9izDRgpcWyI_0N_dGd0mDr4qS8SSLOS2G9G8-0xM4QchzYNVRTrIM5sFjDpXaA8zsFr8IbcJ5nVuKI7uuT5lF3M0tke6Ypxth14v3Noh_Wkpov5ycPd-hsY_Ffcxhwx8eUiH55cg-NNBdsnh-CSBFroqOX5TbgwEHWRNfF5j9tseaQ6cf8utvl40-Q_Xuj8OXnW0kd62uD9guy58iV5MmoXyF-RPwA7PdUlMtE5vcKSPN41INPK0xycz7Iya-CX9Oaedtg4S3E-lo6GwY8xVaWlw2DS7JKZ08lihYljQSYfzOj1GoMF6-zO9DucVguNeoMPBypJx85WD3SA-yWNe02m52eTYR60BRcCA7xtGRhueRYnOtRGcmUAL2ZshKTESyuNZSI1MYZpMWZc7AF_mRntecaBl4SJS96Qg7Iq3TtCpTciihzXGZdMKSa5lqAsqVHKq8SqHvncdXph2mzkWBRjXsCoBBEqAKGiRahHjjfCt00Sjt1iA0RvI4KZs-sL1eJX0Rpi4Qz8xawXwHtD5lOmZSSlj0BBU2mNDHvkqMO-6LSxiAUQSySD8I5Pm9tgiLi6okpXrWqZhAPfFfCIt42qbL4kgeupZFGPiC0l2vrU7Tvlze862bcUSZLy7P1_t_xAnsYYslFPGx2Rg-Vi5T4CkVrqPtkPf-ZwFDPRJ4eDs8urcb-elOjX5vMXBl8l4A
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVAIuiDeGAotULkimfqzX3gNCTdrKbZOoSlMpN-N9QaXILnkI8h_4LfxGZvxICaq49RTJHq02nm92vp3dmSFk19ORl_uBdINEJy4T1ri5xRi8BG_IbZhoiSe6gyFPL9jJJJpskd9tLgxeq2zXxGqh1qXCGPleEINvR3_MPl99d7FrFJ6uti00alicmtUP2LLNPx0fgH7fB8HR4biXuk1XAVcBOVm4imueBKH0pBI8VzApprSPntcKLZRmcaQCzEViTJnAwp8UiZKWJxycrxeaEMa9Q7ZZCFuZDtnuHg7PRtdRnQh2BHFSJwJiC6C9k7T38RxYQRSzDddXdQi4idb-ezvzL3d39JA8aHgq3a-B9YhsmeIxuTtoTuKfkF-AL7ovC6S8U3qGvX-sqdFES0tT8HKLUq2AyNLLOW1BYDTFwC8d9Nz-iOaFpj13XF_HmdLxbIkVakEm7U7o-QqzEqsy0vQAfpYziQDFwYGz0pHR5U_axYuZyjwlF7eig2ekU5SFeUGosCr2fcNlwgXLcya4FIDKSOW5zUOdO-RD-9Ez1ZQ9x-4b0wy2P6ihDDSUNRpyyO5a-Kqu9nGzWBe1txbBEt3Vg3L2NWssPjMKlkttYyDYHrMRk8IXwvpgCZHQSngO2Wl1nzXrxjy7RrlD3q1fg8XjMU5emHJZyYQciHUMQzyvobKeSQjPI8F8h8QbINqY6uab4vJbVVVcxGEY8eTl_6f1ltxLx4N-1j8enr4i9wNMBqkCUjuks5gtzWugaAv5prELSr7ctin-AXEZUjs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ZbxMxELZKkSpeEDcLBYxUXpCW7OG11w8INQlReqSq2lTK27K-oFK0W3II8h_4Rfw6ZvZICap461OkXctydr7xfB7PQcheYJIgDyPlR6lJfSad9XOHPngF1pC7ODUKb3RHJ3x4wQ4nyWSL_G5zYTCsst0Tq43alBp95J1IgG1He8w6rgmLOO0PPl1997GDFN60tu00aogc2dUPOL7NPx70Qdbvomjwedwb-k2HAV8DUVn4mhueRrEKlJY817BApk2IVthJI7VhItER5iUxpm3k4A_LVCvHUw6GOIhtDPPeIXdFnISoY2Iirv07CZwNRFqnBGIzoM7hsPfhHPhBItiGEax6BdxEcP-N0_zL8A0ekPsNY6X7NcQeki1bPCI7o-ZO_jH5BUij-6pA8julp9gFyNkaV7R0dAj2blHqFVBaejmnLRysoegCpqOef3xG88LQnj-uA3OmdDxbYq1aGDPsTuj5CvMTq4LStA8_y5lCqOLkwF7pmTXlT9rFEE1tn5CLW5HAU7JdlIV9Tqh0WoSh5SrlkuU5k1xJwGei89zlsck98r796JluCqBjH45pBgchlFAGEsoaCXlkbz34qq77cfOwLkpvPQSLdVcPytnXrNH9zGrYOI0TQLUD5hKmZCilC0EnEmm0DDyy28o-a3aQeXaNd4-8Xb8G3ccLnbyw5bIaE3Og2AKmeFZDZb2SGJ4nkoUeERsg2ljq5pvi8ltVX1yKOE54-uL_y3pDdkABs-ODk6OX5F6EWSGVZ2qXbC9mS_sKuNpCva6UgpIvt62FfwBAfFUL
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Abnormal+Proliferation+of+Hepatocytes+is+Associated+with+MC-LR+and+C-Terminal+Truncated+HBX+Synergistic+Disturbance+of+the+Redox+Balance&rft.jtitle=Journal+of+hepatocellular+carcinoma&rft.au=Cai%2C+Dong-Mei&rft.au=Mei%2C+Fan-Biao&rft.au=Zhang%2C+Chao-Jun&rft.au=An%2C+San-Chun&rft.date=2022-01-01&rft.pub=Dove&rft.eissn=2253-5969&rft.volume=9&rft.spage=1229&rft.epage=1246&rft_id=info:doi/10.2147%2FJHC.S389574&rft.externalDocID=PMC9733568
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2253-5969&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2253-5969&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2253-5969&client=summon